BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24213972)

  • 1. SLC6A8 creatine transporter deficiency can be detected by plasma creatine and creatinine concentrations.
    Sanders K; Peck D; Bentz Pino G; Studinski Jones A; White A; Gavrilov D; Matern D; Oglesbee D; Schultz M; Tortorelli S; Hall PL
    Mol Genet Metab; 2024 May; 142(1):108455. PubMed ID: 38531184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dodecyl creatine ester therapy: from promise to reality.
    Mabondzo A; van de Kamp J; Mercimek-Andrews S
    Cell Mol Life Sci; 2024 Apr; 81(1):186. PubMed ID: 38632116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency.
    Kurosawa Y; Degrauw TJ; Lindquist DM; Blanco VM; Pyne-Geithman GJ; Daikoku T; Chambers JB; Benoit SC; Clark JF
    J Clin Invest; 2012 Aug; 122(8):2837-46. PubMed ID: 22751104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics, Developmental Trajectory, and Caregiver Burden of Patients With Creatine Transporter Deficiency (
    Curie A; Lion-François L; Valayannopoulos V; Perreton N; Gavanon M; Touil N; Brun-Laurisse A; Gheurbi F; Buchy M; Halep H; Cheillan D; Mercier C; Brassier A; Desnous B; Kassai B; De Lonlay P; Des Portes V
    Neurology; 2024 Apr; 102(8):e209243. PubMed ID: 38531017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing binding and occlusion of substrate in the human creatine transporter-1 by computation and mutagenesis.
    Clarke A; Farr CV; El-Kasaby A; Szöllősi D; Freissmuth M; Sucic S; Stockner T
    Protein Sci; 2024 Jan; 33(1):e4842. PubMed ID: 38032325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is creatine a CNS neurotransmitter?
    Mallik B; Frank CA
    Elife; 2023 Oct; 12():. PubMed ID: 37843902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the efficacy, safety, and cost of alternative forms of creatine available for purchase on Amazon.com: are label claims supported by science?
    Escalante G; Gonzalez AM; St Mart D; Torres M; Echols J; Islas M; Schoenfeld BJ
    Heliyon; 2022 Dec; 8(12):e12113. PubMed ID: 36544833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Delivering Guanidinoacetic Acid or Its Prodrug to the Neural Tissue: Possible Relevance for Creatine Transporter Deficiency.
    Adriano E; Salis A; Damonte G; Millo E; Balestrino M
    Brain Sci; 2022 Jan; 12(1):. PubMed ID: 35053827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Preclinical Models in Creatine Transporter Deficiency: Neurobiological Mechanisms, Biomarkers and Therapeutic Development.
    Ghirardini E; Calugi F; Sagona G; Di Vetta F; Palma M; Battini R; Cioni G; Pizzorusso T; Baroncelli L
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative phosphorylation in creatine transporter deficiency.
    Li S; Bianconi S; van der Veen JW; Dang Do A; Stolinski J; Cecil KM; Hannah-Shmouni F; Porter FD; Shen J
    NMR Biomed; 2021 Jan; 34(1):e4419. PubMed ID: 32990357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American College of Medical Genetics and Genomics.
    Sharer JD; Bodamer O; Longo N; Tortorelli S; Wamelink MM; Young S
    Genet Med; 2017 Feb; 19(2):256-263. PubMed ID: 28055022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of Creatine in the Heart.
    Zervou S; Whittington HJ; Russell AJ; Lygate CA
    Mini Rev Med Chem; 2016; 16(1):19-28. PubMed ID: 26202199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in network connectivity during fictive-gasping generation in hypoxia: prevention by a metabolic intermediate.
    Nieto-Posadas A; Flores-Martínez E; Lorea-Hernández JJ; Rivera-Angulo AJ; Pérez-Ortega JE; Bargas J; Peña-Ortega F
    Front Physiol; 2014; 5():265. PubMed ID: 25101002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of amide creatine derivatives in brain hippocampal slices, and their possible usefulness for curing creatine transporter deficiency.
    Garbati P; Adriano E; Salis A; Ravera S; Damonte G; Millo E; Balestrino M
    Neurochem Res; 2014 Jan; 39(1):37-45. PubMed ID: 24213972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Di-acetyl creatine ethyl ester, a new creatine derivative for the possible treatment of creatine transporter deficiency.
    Adriano E; Gulino M; Arkel M; Salis A; Damonte G; Liessi N; Millo E; Garbati P; Balestrino M
    Neurosci Lett; 2018 Feb; 665():217-223. PubMed ID: 29229397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Searching for a therapy of creatine transporter deficiency: some effects of creatine ethyl ester in brain slices in vitro.
    Adriano E; Garbati P; Damonte G; Salis A; Armirotti A; Balestrino M
    Neuroscience; 2011 Dec; 199():386-93. PubMed ID: 21963865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The creatine transporter mediates the uptake of creatine by brain tissue, but not the uptake of two creatine-derived compounds.
    Lunardi G; Parodi A; Perasso L; Pohvozcheva AV; Scarrone S; Adriano E; Florio T; Gandolfo C; Cupello A; Burov SV; Balestrino M
    Neuroscience; 2006 Nov; 142(4):991-7. PubMed ID: 16949212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked creatine transporter deficiency: clinical aspects and pathophysiology.
    van de Kamp JM; Mancini GM; Salomons GS
    J Inherit Metab Dis; 2014 Sep; 37(5):715-33. PubMed ID: 24789340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of X-linked creatine transporter (SLC6A8) deficiency: systematic review of the literature and three new cases.
    Dunbar M; Jaggumantri S; Sargent M; Stockler-Ipsiroglu S; van Karnebeek CD
    Mol Genet Metab; 2014 Aug; 112(4):259-74. PubMed ID: 24953403
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.